Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein

Cancer Lett. 2001 Mar 10;164(1):77-84. doi: 10.1016/s0304-3835(00)00720-5.

Abstract

5 Fluorouracil (5 FU), the most effective systemic chemotherapeutic agent in the management of advanced colorectal carcinoma acts by inducing apoptosis. Response rates, approximately 20% is improved by folinic acid. This study investigates similar modulation of 5 FU-induced apoptosis by oxidant quenching. A five-fold reduction of intracellular oxidant levels by antioxidants N-acetylcysteine and vitamin E did not induce apoptosis, it however augmented pro-apoptotic bax protein expression, and apoptotic response to a non-toxic dose of 5 FU in the colorectal cancer cell lines colo 201 and colo 205. This suggests that reduction of intracellular levels of reactive oxygen species enhance susceptibility to 5 FU (apoptotic stimuli) by augmentation of bax expression.

MeSH terms

  • Acetylcysteine / pharmacology
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antioxidants / therapeutic use*
  • Apoptosis
  • Blotting, Western
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / genetics*
  • Drug Interactions
  • Flow Cytometry
  • Fluorouracil / therapeutic use*
  • Free Radical Scavengers / pharmacology
  • Humans
  • Oxidation-Reduction
  • Proto-Oncogene Proteins / biosynthesis*
  • Proto-Oncogene Proteins c-bcl-2*
  • Reactive Oxygen Species
  • Time Factors
  • Tumor Cells, Cultured
  • Vitamin E / pharmacology
  • bcl-2-Associated X Protein

Substances

  • Antimetabolites, Antineoplastic
  • Antioxidants
  • BAX protein, human
  • Free Radical Scavengers
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • bcl-2-Associated X Protein
  • Vitamin E
  • Fluorouracil
  • Acetylcysteine